Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-09-27, Stock:NVO, The news for the past five days is as follows:
2019-09-20: NEWS1: UPDATE 2-Novo Nordisk wins U.S. approval for first-of-its-kind oral diabetes drug.NEWS2: UPDATE 2-European shares log fifth week of gains, Novo Nordisk shines.
2019-09-23: NEWS1: Novo Nordisk's Semaglutide in Tablet Form Gets FDA Approval.NEWS2: Lilly Gets CHMP Nod to Add Heart Indication to Trulicity Label.NEWS3: Novo Nordisk targets bigger slice of diabetes market with new tablet.
2019-09-24: NEWS1: Novo Nordisk A/S -- Moody's announces completion of a periodic review of ratings of Novo Nordisk A/S.NEWS2: How Novo Nordisk Is Aiming To Take A Slice Of Lilly's Diabetes Market.NEWS3: What The Price Tag Says About Novo Nordisk's Newest Diabetes Drug.NEWS4: Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023.
2019-09-25: NEWS1: Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023.NEWS2: Loyalty shares can promote better long-term stewardship .
2019-09-26: NEWS1: Foreign Firms Recognized as Hottest Biotechs.NEWS2: Enanta's Stock Down Despite NASH Drug Meeting Goal in Study.

Answer: Decrease